The Asian Dermatology Devices market is estimated to grow at a CAGR of 11.3% from 2014 to 2019. China holds a larger share in the Dermatology devices market around 28.8% in 2014 followed by Japan. The Asian Dermatology Devices market holds a high potential for growth in future due to a number of forces favoring this market. These include increasing number of people suffering from skin disorders, demand for devices at a lower cost and increasing awareness aesthetic procedures. However, price sensitive market is having an adverse effect on the dermatology devices market.
In this report, the Asian Dermatology devices market is broadly classified on the basis of product types, end users. The products segment is classified into Dermatology treatment devices and Dermatology diagnostic devices. Based on end users, the Dermatology devices market is categorized into Hospitals and Clinics.
Geographically the market is divided into eight countries, namely Japan, China, India, Korea, Singapore, Malaysia, Indonesia and Rest of Asia (RoE). China is estimated to command the largest share of 28.7% of the Asian Dermatology Devices market in 2014, followed by Japan. Japan is estimated to grow at a CAGR of 7.9% during the forecast period from 2014 to 2019.
Certain factors that influence the demand for the Asian dermatology devices market include the increasing number of people who suffer from skin disorders and the demand for devices at a lower cost. Thus, world-class manufacturers are coming up with devices at a lower price and concentrate on the Asian region to expand their business and geographical reach. Countries in the Asian region, namely India and China have a tropical climate, making the inhabitants of this region extremely prone to sun exposure, particularly skin tanning. Thus, there is an increase in the demand for dermatological treatments that have an impact on the growth of the dermatology diagnostic devices market in Asia. The number of skin cancer cases in Singapore has been increasing. There were 2,819 cases of skin cancer in Singapore from 2008 to 2012, among which 83.0% were Chinese, according to the National Skin Centre, followed by Malays recording 4.5% of the cases.
The report has profiled the leading players of this market along with the developments (New product launches and partnerships, agreements, collaborations, and joint ventures) done by the companies over the past few years and strategies adopted by them to sustain and strengthen their position in the Asian Dermatology Devices market. Heine Optotechnik (Germany), Optomed Oy (Finland), FotoFinder Systems (Germany), Michelson diagnostics (UK), Genesis Biosystems (U.S.), Ellipse A/S (Denmark), Alma Lasers (Israel), Palomar Technologies (U.S.), GE Healthcare (UK), and Philips Healthcare (Netherlands), HEINE Optotechnik (Germany), 3Gen LLC (U.S.), Welch Allyn (U.S.), Carl Zeiss Meditec, Inc. (U.S.), Hitachi (Japan), Leica Microsystems (Germany), Olympus (Japan), GE Healthcare (U.K.), Phillips Healthcare (Netherlands), Toshiba Medical Systems (Japan), and Siemens Medical Systems (Germany). are some of the key players engaged in this market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments of the Asian Dermatology Devices market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market, share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.
The report provides insights on the following pointers:
Supply Chain Analysis:
Eminent players providing dermatology devices, original equipment manufacturers (OEMs), distributors, and end customers (hospitals and clinics) are the key stakeholders in the supply chain. The dermatologists, physicians, practitioners, caregivers, researchers and scientists, investors/funders, and regulatory bodies are major influencers.
The eminent players are basically the well-established and financially viable entities operating in the market for a very long time and have carved a niche for themselves across the market.
They have a potential hold over the market generating an enhanced bottom line by maintaining a diversified product mix, sound geographical expansion, extensive distribution network, and high economies of scale. Certain matured companies in this market include Nikon Corporation (Japan), Olympus Corporation (Japan), Carl Zeiss (U.S.), Alma Lasers Ltd (Israel), and Lumenis (Israel).
Impact Analysis: Impact of increasing incidence of skin disorders like melanoma of skin, psoriasis on the demand for dermatology devices (diagnostic and treatment devices). Impact of demand of aesthetic beautification.